Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Prostate Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07623642
What this trial is testing

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

Who this might be right for
Uterine Cervical NeoplasmsTriple Negative Breast NeoplasmsProstatic Neoplasms+8 more
GV20 Therapeutics 227
Testing effectiveness (Phase 2)Study completedNCT01065441
What this trial is testing

Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

Who this might be right for
Solid Tumors Stage II, Stage III and Stage IVBreast CancerColorectal Cancer+5 more
Michael Har-Noy 9
Large-scale testing (Phase 3)Study completedNCT00046943
What this trial is testing

Atrasentan in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Abbott
Not applicableLooking for participantsNCT03880422
What this trial is testing

Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer

Who this might be right for
Cancer SurvivorObesityOverweight+17 more
Roswell Park Cancer Institute 50
Not applicableStudy completedNCT03963739
What this trial is testing

Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage II Prostate Cancer+1 more
Wake Forest University Health Sciences 255
Testing effectiveness (Phase 2)Ended earlyNCT03964337
What this trial is testing

Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer

Who this might be right for
Prostate CancerProstate Cancer AdenocarcinomaNon-Metastatic
Duke University 3
Not applicableStudy completedNCT00535834
What this trial is testing

Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 48
Testing effectiveness (Phase 2)Ended earlyNCT00814892
What this trial is testing

Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Mayo Clinic 2
Early research (Phase 1)Study completedNCT00026377
What this trial is testing

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Chicago 3
Testing effectiveness (Phase 2)Study completedNCT00022412
What this trial is testing

Doxercalciferol Before Surgery in Treating Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 60
Testing effectiveness (Phase 2)Study completedNCT00528866
What this trial is testing

Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 80
Not applicableActive Not RecruitingNCT02176902
What this trial is testing

Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateStage I Prostate CancerStage IIA Prostate Cancer+1 more
Jonsson Comprehensive Cancer Center 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT05053152
What this trial is testing

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Who this might be right for
Oligometastatic Prostate CarcinomaProstate AdenocarcinomaProstate Ductal Adenocarcinoma+2 more
NRG Oncology 194
Testing effectiveness (Phase 2)Study completedNCT02058706
What this trial is testing

LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
Barbara Ann Karmanos Cancer Institute 71
Testing effectiveness (Phase 2)Study completedNCT00025116
What this trial is testing

ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
NCIC Clinical Trials Group 40
Testing effectiveness (Phase 2)Study completedNCT00040755
What this trial is testing

BMS-275291 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Adenocarcinoma of the ProstateBone MetastasesHormone-resistant Prostate Cancer+2 more
National Cancer Institute (NCI) 68
Large-scale testing (Phase 3)Study completedNCT03274687
What this trial is testing

Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7+1 more
NRG Oncology 296
Large-scale testing (Phase 3)Study completedNCT00033631
What this trial is testing

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,534
Large-scale testing (Phase 3)Study completedNCT00002511
What this trial is testing

Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,005
Large-scale testing (Phase 3)Study completedNCT00769548
What this trial is testing

Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,322
Next Page